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Background: There is increasing scientific knowledge about the interaction between physiological
(musculoskeletal, neuromuscular, cognitive and sensory) systems and their influence on balance and walking
impairments in Parkinson’s disease. We have developed a new conceptual framework for balance training,
emphasising specific components of balance control related to Parkinson’s disease symptoms by using highly
challenging, progressive and varying training conditions. The primary aim of this proposed randomised controlled
trial will be to investigate the short-term and long-term effects of a 10-week balance training regime in elderly
with Parkinson’s disease.
Methods/Design: Eighty participants with mild to moderate idiopathic Parkinson’s disease will be recruited and
randomly allocated to an intervention group receiving balance training or a control group whose participants
will continue to receive their usual care. The intervention will consist of a 10-week group training regime (1-hour
training, three times per week), which will be led by two physiotherapists to ensure training progression and safety.
The conceptual framework will be applied by addressing specific balance components (sensory integration,
anticipatory postural adjustments, motor agility, stability limits) through varying training conditions and structured
progression. Assessment will be conducted through a multi-dimensional battery of outcomes, prior to and
immediately after the 10-week intervention, and at 9 and 15 months’ follow-up after entering the study. Primary
outcome measures will be balance performance (assessed using the Mini Balance Evaluation Systems Test), change
in gait velocity (m/s) between single and dual task walking, and fear of falling (evaluated using the Fall Efficacy
Scale International).
Discussion: This study has the potential to provide new insight and knowledge of the effects of specific, varied
and challenging balance training on a wide health spectrum in elderly with PD. If found to be effective, this
pragmatic approach with translation of theory into practice, can be implemented in existing outpatient care.
Trial registration: NCT01417598Background
Parkinson’s disease (PD) is a major worldwide health
problem [1], with a reported incidence rate ranging from
11 to 19/100,000 per year in the European population
[2]. Balance and walking impairments are present even
in the early stages of PD [3-6] and have been shown to* Correspondence: David.Conradsson.1@ki.se
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distribution, and reproduction in any mediumbe associated with restrictions in everyday activities [7]
and reduced quality of life (QoL) [8].
Furthermore, elderly with PD have shown reduced
levels of physical activity [9] and a nine times increased
risk of injurious falls, compared with the healthy elderly
[10]. As PD progresses, balance problems gradually
increase and are generally non-responsive to or worsen
with levodopa treatment [11-13]. Currently, there is a
growing body of research that highlights the role of
physical exercise as an essential part of managing the
disease, with potential neuroprotective mechanisms
[14,15]. The effects of balance training on balance andntral Ltd. This is an Open Access article distributed under the terms of the
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[16-18], although several questions remain unanswered,
particularly regarding dose, intensity and duration, as
well as regarding specific exercises to improve balance
control in the different stages of the disease [17-21].
Additionally, there is a lack of knowledge of the long-
term effects of training interventions on participation in
everyday living, such as physical activity and QoL [16].
Balance control relies on the interaction of several
physiological systems (the musculoskeletal, neuromuscu-
lar, cognitive and sensory systems) with environmental
factors and the performed task [22]. Balance impairment
or postural instability in individuals with PD is often
associated with poor or absent reactive responses follow-
ing external perturbations, such as performing a rapid
step following a slip or trip [23]. However, as degener-
ation of the basal ganglia affects many physiological
systems essential for balance control, balance disorders
in PD cannot be addressed to one single function but,
rather, are the result of impairments of multiple systems
[24-26]. First of all, dysfunction of the basal ganglia
influences sensory integration, i.e. the ability of the cen-
tral nervous system to transform different modalities of
sensory information (somatosensory, visual and vestibu-
lar) into a single reference frame, which is important for
estimation of limb and body position in relation to the
environment [27]. Particularly, individuals with PD have
shown impaired proprioception [13,27], overestimation
of the amplitude of movements [28] and over-reliance
on vision for balance control [29]. Moreover, the central
motor drive has shown to be impaired in PD [30], caus-
ing bradykinetic movements and poorly timed and
scaled anticipatory postural adjustments (APAs), i.e.
feedforward control to stabilise the posture before and
during voluntary movements [31,32]. Furthermore, the
PD-characteristic “stooped” posture, decreased joint
range of motion, narrow foot stance and axial rigidity in-
crease the risk of instability since these musculoskeletal
constraints reduce the functional limits of stability, i.e.
the area in which the body centre of mass (CoM) can be
moved with maintained stability and without changing
the base of support (BoS) [33,34]. Taken together,
sensory-motor interaction is essential for balance control
and consequently, as discussed by Konczak et al. [27],
sensory problems may degrade movement responses and
cause instability to individuals with PD.
The functions of the basal ganglia incorporate motor
program selection and adaptation [35,36], here referred
to as motor agility, which involves maintenance of
coordination between body parts, task-specific adjust-
ments of movement and quick shifts from one task to
the next. Deficient motor regulation in PD, manifested
as poor inter-segmental coordination [37], problems
adopting postural synergies [35,38] and delayed changeof motor commands when shifting from one task to
another [39], is believed to contribute to increased
instability and freezing of gait during fall-related activ-
ities [40,41]. Another critical aspect of balance control
in PD is the ability to divide attention and simultan-
eously process multiple tasks (motor or cognitive), i.e.
multi-tasking. While performing a multi-task activity,
individuals with PD compared with healthy subjects
are more inclined to shift attention away from the bal-
ance task, which can lead to falls [24].
To be successful, all types of training require the appli-
cation of basic training principles of (i) specificity, i.e.
being specific to the targeted function; (ii) progressive
overload, i.e. providing a challenging overload to the
physiological system through a certain level of intensity
and regularity; and (iii) varied practice, i.e. promoting
variation between exercise conditions [42,43]. To be spe-
cific, balance training needs to target functions, or
impairments, of balance control associated with PD
symptoms. As previously mentioned, there is increasing
scientific knowledge concerning the interaction between
and impact of different physiological systems for balance
disorders in PD [24-26]. Previous intervention studies
targeting balance performance in PD have, however,
mainly emphasised non-specific training or compensa-
tory training [17,44]. Moreover, to stimulate relearning
of physiological systems important for balance control,
the challenge level (i.e. intensity of the training, the diffi-
culty level of balance exercises and the total training
dose) needs to be considered. Allen et al. [17] recently
concluded, based on a meta-analysis of exercise inter-
ventions targeting balance performance in PD, that pre-
vious studies in general have used low challenge levels,
suggesting that future exercise interventions should
focus on more challenging aspects of balance exercises
and a higher training dose. Furthermore, to enhance
generalisation of learned motor skills to a wide variety
of situations and promote a multi-faceted repertoire
of movement strategies, it is essential to guarantee prac-
tice through a wide variety of balance exercise condi-
tions [43].
We hypothesise that a new conceptual framework for
balance training, emphasising critical aspects of balance
control specifically related to PD symptoms through
highly challenging, progressive and varied exercises, will
improve, or maintain, balance and gait performance in
elderly with PD. Moreover, we predict that increased
physical functioning following training will lead to
greater confidence in everyday participation, improved
QoL and increased levels of physical activity.
The primary aim of this proposed randomised con-
trolled trial will be to expose elderly individuals with
mild to moderate PD to a 10-week balance training
regime, and compare the efficacy of balance training
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In a prospective, randomised controlled clinical trial,
with 9 and 15 months’ post-baseline follow-up, 80 eld-
erly patients with PD living in Stockholm County,
Sweden, will be included. The project has been approved
by the Regional Board of Ethics in Stockholm (Dnr:
2009/819-32 and 2010/1472-32).
Participant selection
Community-dwelling individuals with PD will be re-
cruited from Karolinska University Hospital, the Swedish
Parkinson Associations and outpatient neurological
clinics as well as by physicians with a specialty in neur-
ology in Stockholm County. Advertisements in local
newspapers will also be used to recruit participants.
Potential participants will receive written information
about the aims of the study and its procedure, with an
invitation to indicate their interest in participating to the
study coordinator. Inclusion criteria will be a clinical
diagnosis of “idiopathic” PD, according to the Queens
Square Brain Bank criteria, ≥60 years of age, have
adapted to their present PD-medication and the ability
to independently ambulate indoors without a walking
aid. We will include mild to moderate PD (Hoehn and
Yahr scores II and III) [45], since physical group training
has been proved feasible for this level of disease severity
[46,47]. Exclusion criteria will be a history suggesting
“atypical” PD symptoms, as defined by Hughes et al.
[48], a Mini-Mental State Examination (MMSE) score
≤24 [49] and other existing neuromuscular disorders or
medical conditions that substantially influences their gait
and balance performance or their participation in the
training program. To screen potential participants’ eligi-
bility, a physiotherapist will conduct a telephone inter-
view based on a clinical self-report form covering
questions about personal and medical history and self-
perceived balance performance.
Randomisation
Participants will be divided into two geographic cohorts
(south and north) to reduce the travelling time for the
participants. After baseline assessments, the participants
in each cohort will be randomly assigned to two differ-
ent groups in blocks of four, one experimental group
with balance training and one control group. The se-
quence of allocation will be performed using web-based
software and will be concealed to the participants and
testers until the baseline measurement is completed.Blinding of group allocation will, however, not be pos-
sible since the test leaders will be supervising the train-
ing intervention (as described below).Intervention group
We have applied the training principles of specificity,
varied practice and progressive overload to design a con-
ceptual framework for balance training in PD. The
framework comprises specific exercises associated with
balance and walking constraints in PD (Table 1). The
intervention period is divided into three blocks (A, B
and C) to promote appropriate progressive overload
through the course of training (Table 2). Implementation
of the training principles for balance training and motor
learning is outlined below.Specificity
In contrast to non-specific training in PD [17], King and
Horak [25] recently proposed a symptom-specific train-
ing approach targeting particular mobility impairments
in individuals with PD. Our approach towards balance
training resembles theirs regarding the principle of spe-
cificity. In the proposed intervention, we will use four
balance components (sensory integration, APAs, motor
agility, and stability limits) to target symptom-specific
balance impairments associated with instability and falls
in PD (see Table 1). The applications of these balance
components will be separated according to exercise
principles and objectives.Varied practice
Through the course of training, exercise variation will be
emphasised to enhance motor learning and promote
generalisation of balance skills to everyday activities [43].
Based on previous findings, individuals with PD, com-
pared with healthy individuals, need more time to
achieve motor learning [50,51]. Therefore, as illustrated
in Table 2, variation in the training will be increased suc-
cessively through the course of training. During the ini-
tial phase of training (Block A), the exercise for each
balance component will be trained separately in blocks
on a weekly basis, to encourage familiarity of the princi-
ples and objectives and promote task-specific motor
learning. In the later phases of training (Blocks B and
C), generalisation of motor skills will be facilitated by
increasing training variation with regard to characteris-
tics of exercise in each balance component (e.g. variation
in terms of body position, BoS and movement direction/
velocity/amplitude) in Block B, and by integrating exer-
cises from different balance components in Block C.
In addition, multi-task exercises in Blocks B and C will
further increase training variation (see Table 2).
Table 1 Parkinson’s disease (PD) specific balance components, constraints affecting balance and exercises designed to
reduce these constraints
Balance components Constraints in PD Exercise principles Exercise objectives
SENSORY INTEGRATION
Integration of sensory information
(somatosensory, visual and vestibular)
for estimation of body position
- Impaired somatosensory integration Walking tasks on varying surface
with or without visual constraints





Prediction and control of perturbation
related to voluntary movements
- Poorly timed and scaled APAs Voluntary arm/leg/trunk movements
focusing on movement velocity and
amplitude, and postural transitions
Improve APA strategies
regarding quality (timing,




Coordination between body parts
and movement adaptation,
e.g. regulation of movement and
quick shifts between tasks
- Bradykinesia Whole-body coordination during
varying gait conditions and reciprocal
movements. Quick shifts of movement
characteristics (velocity, amplitude
and direction) during predictable and
unpredictable conditions
Improve whole-body
coordination, ability to adapt
movement and quick shifts
between different tasks
- Impaired whole-body coordination
- Biomechanical constraints
- Inflexible motor programming
STABILITY LIMITS
Whole-body regulation relative to
the BoS
- Reduced functional stability limits Voluntary leaning tasks in standing
with varying BoS-stimulating weight
shifts in multiple directions through
arm and trunk movements
Improve the ability to safely
control CoM within BoS to




- Impaired somatosensory integration
APAs = anticipatory postural adjustments; BoS = base of support; CoM= centre of mass.
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Based on previous recommendations [17] and national
guidelines for physical training [52], as well as our ex-
perience from a pilot study of balance training in PD
(data not yet published) and balance training in elderly
[53], we believe that the training frequency, duration
and total training dose planned for use in the proposed
study (three 1-hour sessions/week during 10 weeks)
will be sufficient to improve balance performance inTable 2 Training progression
Training principles and objectives Wee
A Introduction of performance of each balance component
separately and emphasizing quality of performance to
accomplish familiarity and task-specific motor learning.
1
2
B Improvement of balance performance and strategies of
attention in varying balance conditions through increased
level of difficulty and task variation for each balance
component separately, and by using multi-tasking





C Further challenging of movement complexity through
increased levels of difficulty, task variation by successively
integrating the balance components, and increasing demands






The balance program divided into three blocks (Blocks A-C), with training principles
APAs = anticipatory postural adjustments; C-DT = cognitive dual-task training; M-DT
dual-task training.elderly with mild to moderate PD. To achieve optimised
challenges to individual capacities, the physiotherapists
will individually adjust the difficulty level of the exercises
for each balance component as follows:
– Sensory integration: increased surface unevenness
and restricted field of vision (vision-restricting
glasses, carrying an object)
– APAs: increased movement amplitude and velocityk Balance components Multi-task
Motor agility/stability limits
Sensory integration/APAs
Motor agility/stability limits C-DT
Sensory integration/APAs M-DT
Motor agility/stability limits C-DT
Sensory integration/APAs M-DT
Sensory integration/APAs/motor agility/stability limits C +M-DT
Sensory integration/APAs/motor agility/stability limits C +M-DT
Sensory integration/APAs/motor agility/stability limits C +M-DT
Sensory integration/APAs/motor agility/stability limits C +M-DT
and objectives for each block.
=motor dual-task training; C +M-DT =mixed cognitive and motor
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velocity, step patterns, etc.), increased gait demands
according to planned (awareness of upcoming
sequences/tasks) and unplanned shifts upon verbal
commands (unawareness of upcoming sequences/
tasks) between different gait conditions, reciprocal
movements and walking directions
– Stability limits: changing the area or condition of
the BoS and increasing leaning movement amplitude
Intermittent presence of reactive postural adjustments
will be used as an indicator of the appropriate difficulty
level. To target multi-task performance in PD, cognitive
(e.g. counting, remembering items/numbers) and sec-
ondary motor tasks (e.g. carrying and/or manipulating
objects) [54], will be introduced in Block B and further
progressed in Block C (see Table 2). Multi-task training
will be individually adjusted for each participant. The
level of difficulty for the secondary tasks (motor or cog-
nitive) will be considered appropriate if the primary task
is affected (e.g. decreased gait velocity or increased stride
variation). Moreover, as described above, training
demands will additionally be challenged by increasing
variation through the course of the program.
Feedback
In individuals with PD, goal-oriented oral feedback that
addresses information externally to the body, i.e. con-
cerning the performance of the task in relation to the
environment (rather than the position or motion of the
body), has been reported to enhance walking [55] and
balance performance [56]. In the proposed trial, oral
feedback will be as simple as possible and be externally
oriented to promote movement automaticity. Cueing
strategies (visual or oral), as described by Nieuwboer
et al. [57], will be used when needed for participants
experiencing severe freezing through the course of
training; however, they will not be used as a standard
training component.
Training/intervention procedure
The balance training will be performed in groups of five
to seven participants in the facilities of the Physiother-
apy Clinic at Karolinska University Hospital. To secure
progression and safety, all training sessions will be led by
two physiotherapists with experience of working with
PD and elderly patients. To standardise the intervention
and secure adherence to the proposed theoretical frame-
work, all physiotherapists will participate in a theoretical
and practical workshop before the intervention starts
and will be supervised during the course of the training.
Every training session will start with a warm-up session
for 5 min, consisting of varied walking tasks aiming to
boost the cardiovascular system. The following 50 min(short rests included) will focus on highly challenging ex-
ercise blocks (approximately 10 min per block) of standing
and walking conditions. The balance components of sta-
bility limits and APAs will mainly be addressed through
standing exercises, and the balance components of motor
agility and sensory integration will mainly be addressed in
walking exercise conditions.
The program will end with a 5-min cool-down session
with slow walking, axial stretching and breathing exer-
cises. The number of exercise blocks for each training
occasion and the distribution between standing and
walking exercises will be adjusted to the level of ability
in each group. After each training occasion, individuals’
performance of the exercises included will be briefly
documented, as an evaluation of both the appropriate-
ness of exercises and the current level of difficulty.
Adverse events (defined as an injury or medical event
that restricts everyday activities and participation in the
intervention) and training adherence will be monitored
and recorded [58].
Exercise on prescription
We predict that increased physical functioning following
training will lead to greater confidence in everyday par-
ticipation and therefore an increased level of physical
activity. However, targeted advice is needed for long-
term behavioural change [59,60]. Therefore, a meeting
will take place after the last training session, where the
participants will participate in a group discussion, led by
physiotherapists, on how to sustain or increase their
level of physical activity. Participants will be given
Physical Activity on Prescription (PaP) [59,60], to-
gether with a leaflet on benefits of physical activity
and health in PD.
Control group
The subjects in the control group will receive usual care
from their medical practitioner and/or the community ser-
vices, and will not be restricted in participating in ongoing
rehabilitation programs. The control group will be offered
the same balance program after study termination.
Outcome measures and test procedure
According to the wide disability spectrum associated
with balance impairments in PD [16,61], a multi-
dimensional battery of outcomes will be used to identify
potential training effects. As illustrated in Table 3, we
have applied the International Classification of Function-
ing, Disability and Health (ICF) as a conceptual frame-
work to target relevant constructs of body functions (i.e.
physiological functions of body systems), activity (i.e.
execution of a task or action by an individual) and par-
ticipation (i.e. involvement in a life situation) [62]. As
previously suggested by Dibble et al. [16], our outcome
Table 3 Classification of outcome measures using the International Classification of Functioning, Disability and Health
(ICF)
ICF
Instruments Domains Body functions Activity Participation
Laboratory tests
- Electronic walkway* Temporal and spatial gait parameters during single/multi-tasking conditions X X
- Mod-CTSIB Sensory integration X
Clinical tests
- Mini-BESTest Subdomains of balance performance X X
- One-leg stance test Balance performance, standing on one leg X
- Modified figure of eight test Balance performance, walking in a figure of eight with reduced BoS X
Free-living assessment
- Accelerometer Physical activity X
Questionnaires
- FES-I Fear of falling X
- UPDRS ADL Activities of daily living X
- SF-36 Generic health-related QoL X
- PDQ-39 PD-specific health-related QoL X
*GAITRite, CIR Systems Inc., Clifton, NJ, USA.
BoS = base of support; PD= Parkinson’s disease; QoL = quality of life.
FES-I = Fall Efficacy Scale International; Mini-BESTest=Mini Balance Evaluation Systems Test; Mod-CTSIB =Modified Clinical Test of Sensory Interaction and Balance;
PDQ-39 = Parkinson’s Disease Questionnaire; SF-36 = 36-item Short-Form Health Survey; UPDRS ADL= the activities of daily living (ADL) section of the Unified.
Parkinson’s Disease Rating Scale, part II.
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of disability and health, from laboratory measurement of
balance and gait performance, to free-living assessment
of physical activity and self-perceived domains of QoL
and participation in everyday living (see Table 3). Pri-
mary outcome measures will be functional balance per-
formance, change in gait velocity (m/s) between single
and dual task walking, and fear of falling.
Participants in both the intervention and the control
group will be tested prior to and after the 10-week inter-
vention, and at 9 and 15 months’ follow-up after enter-
ing the study. All physical measurements will be
conducted during the ON phase of their levodopa medi-
cation and at the same time of day to restrict the influ-
ence of medication fluctuations. The order of the
physical tests (laboratory and clinical, as described
below) will be randomised for each participant to avoid
systematic bias.
Laboratory tests Temporal and spatial gait parameters
will be measured using a 9 m electronic walkway (GAI-
TRite, CIR Systems Inc., Clifton, NJ, USA) sensing the
geometry of each step through embedded pressure sen-
sors. Four types of gait conditions will be evaluated during
(i) self-selected and (ii) fast speed, (iii) while performing a
cognitive (reciting every second letter of the alphabet) and
(iv) a motor dual-task (carrying a tray with a glass of water).
Spatial and temporal gait parameters will be analysed, as
will variability and asymmetry in gait performance.The Modified Clinical Test of Sensory Interaction and
Balance (Mod-CTSIB) will be used to measure sensory
integration during static standing [63]. To discriminate
between the sensory systems (somatosensory, visual and
vestibular), participants will be timed while standing
on a force plate (50 cm x 50 cm; Kistler, Winterthur,
Switzerland) in four different sensory conditions: (i) stand-
ing on a firm surface with the eyes open; (ii) standing on a
firm surface with the eyes closed; (iii) standing on a com-
pliant surface with the eyes open; and (iv) standing on a
compliant surface with the eyes closed. Outcomes will be
the time able to stand (max 30 s) and postural sway in
the anterior-posterior and medio-lateral direction.Clinical tests The Mini Balance Evaluation Systems Test
(Mini-BESTest) will be used to assess underlying subsys-
tems of balance performance (APAs, postural reactive
responses, sensory integration and dynamic gait) [64].
The One-leg stance test will be performed with the
subject standing on one leg as long as they are able to
[65]. This test requires appropriate APAs for CoM tran-
sition from a standing position to a restricted BoS.
The Modified figure of eight test will be used to evalu-
ate dynamic balance during walking [66]. The subject is
instructed to walk in a figure of eight (marked with
40 mm-wide tape on the floor, each loop having an
internal diameter of 1.63 m) as fast as possible, with
every step touching the tape [66].
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will be assessed with accelerometers (Actigraph GT3X+,
Manufacturing Technology Inc., Fort Walton Beach, FL,
USA). The accelerometer will be used under free-living
conditions, worn around the waist, using an elasticized
belt, for 7 consecutive days. Outcomes will be total
physical activity, expressed as counts per minute and
steps per day, and time spent on different intensity levels
as well as time spent sedentary [67].
Questionnaires The Activities of Daily Living section of
the Unified Parkinson’s Disease Rating Scale (UPDRS
ADL), part II, will be used to measure activities of daily
living [68].
The Falls Efficacy Scale International-I (FES-I) will
be used to measure participants concern of fear of fall-
ing during a variety everyday activities (e.g. getting
dressed, taking a shower, climbing stairs or going to the
shop) [69].
As previously suggested by Brown et al. (2009), assess-
ment of Health-related QoL in PD should include both a
generic and a PD-specific instrument [70]. The Short
Form-36 (SF-36) will be used to evaluate generic health-
related QoL [70,71] and the 39-item Parkinson’s Disease
Questionnaire (PDQ-39) will be used to evaluate PD-
specific health-related QoL [70,72].
Statistical analysis
Descriptive statistics will be performed to ensure com-
parability between scores at baseline as well as to test
the assumption of homogeneity of variance for use of
parametric statistics. To evaluate the effect of the inter-
vention, mixed models (SPSS Inc., Chicago, IL, USA)
with an alpha level of 0.05 will be used where appropri-
ate. Significance of main or interaction effects will be
explored using the Bonferroni post hoc test. In case of
skewed distributed data, logarithmic transformations or
corresponding non-parametric statistics will be used to
assess main effects of the intervention.
Sample size
The sample size for this study was determined from a
pilot study (not yet published), including five mild to
moderate PD subjects who participated in the proposed
balance training, and also from previous trials on
patients with PD and elderly people [53,73,74]. For
each sample size calculation, power was set at 80% and a
two-sided test at the alpha level of 5%. For the Mini-
BESTest, a sample size of 24 was required to detect a 3-
point difference between groups, assuming a mean vari-
ance or standard deviation (SD) of 3.6 (effect size: 0.83).
For the interference effect of dual task performance, i.e.
percent change in gait velocity (m/s) between single and
dual task walking [74], a sample size of 27 subjects wasrequired to detect a difference of 10% (SD 13) between
groups (effect size = 0.77). Finally, for the FES- I, a sam-
ple size of 32 subjects was required to detect a difference
of 2 points (SD 2.8) between groups (effect size = 0.71).
The dropout rate was set at 15%, corresponding to inter-
vention studies with PD subjects [75,76]. Taken together,
to ensure adequate statistical power the sample size for
this study would optimally be 40 per group (total
n = 80).Discussion
In this study protocol, a conceptual framework based on
current scientific knowledge from neuroscience con-
straints in PD is used to design a training intervention
targeting balance and walking performance in PD. The
rationale for this training approach relies on findings of
preserved motor learning in mild to moderate stages of
PD [51] and the plausibility of training-induced neuro-
protection [14,15]. Although previous exercise interven-
tions in PD have reported promising results for balance
and gait performance [16-18], they often lack to report
the underlying principles of the intervention [21]. In par-
ticular, knowledge concerning the influence of active ele-
ments of the intervention (e.g. exercise components,
training dosage and intensity) is limited [21]. In contrast
to the majority of previous training regimes that empha-
sise general physical training [17] or target single physio-
logical systems (e.g. muscular strength, reactive postural
adjustments), the active elements in this intervention
cover traditional training principles of specificity, pro-
gressive overload and random training. Hence, these
principles are modified to promote motor learning in
PD through specific balance components related to PD
symptoms during highly challenging and varying exer-
cise conditions. There is an urgent need to investigate
both short-term and long-term effects of new exercise
strategies targeting balance control in PD [17].
Balance impairment in PD comprises a wide spectrum
of disability and health [16]. Detailed long-term follow-
up, 1 year post-intervention, in the proposed study will
give a unique opportunity to address important ques-
tions concerning potential effects of and limitations for
group-based balance training. First of all, the proposed
study will be one of the first trials to provide knowledge
of potential effects of exercise intervention according to
the whole spectra of ICF domains, including laboratory
measurements, clinical tests, and free-living and self-
perceived assessments (see Table 3). Such knowledge will
be essential for designing and improving exercise inter-
ventions in the future. Secondly, long-term follow-up
will provide knowledge of the maintenance of potential
training effects. This is particularly important for PD
given the progressive deterioration of the disease in
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may be required to sustain physical performance.
Since this intervention will not be restricted to a fixed
program with specific exercises, several steps will need
to be taken to standardise the intervention by educating
physiotherapists in the framework and implementation
of the training approach, as well as supervising the phy-
siotherapists during the course of training and monitor-
ing training performance as well as progression. During
the course of training, each training session is planned
with regard to the different phases of the intervention
(see Table 2) and adapted by the physiotherapist to meet
individual capacities of the participants. The phy-
siotherapists conducting the training will be responsible
for transferring the conceptual framework into practice,
using a pragmatic approach rather than restricting the
intervention to a standardised protocol. Thus, transla-
tion of this research intervention into the clinical setting
will be enhanced.
There are several limitations to the proposed study.
The result of this intervention can only be generalised to
individuals with mild to moderate PD [45] and group
training in outpatient care. All measurements will be
conducted at the same time of the day during the ON
phase of levodopa medication. The total dose of medica-
tion will be monitored in a longitudinal perspective [77],
though separating the potential effects of balance train-
ing from those of levodopa medication will be limited.
Moreover, blinding of the test leaders will not be pos-
sible since they also will serve as support for the phy-
siotherapists conducting the intervention. However, this
proposed randomised controlled trial has the potential
to provide new knowledge and a change in focus con-
cerning balance interventions in PD.Competing interests
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